Brief: Redwood Pharma: Asian Pharmaceutical Firm To Evaluate IntelliGel
Feb 26 (Reuters) - REDWOOD PHARMA AB REDWPH.TE :
* ASIAN PHARMACEUTICAL FIRM TO EVALUATE INTELLIGEL
* ASIAN PHARMACEUTICAL FIRM WILL OBTAIN INTELLIGEL FOR
PURPOSES
OF EVALUATING DRUG DELIVERY PLATFORM
* AGREEMENT DOES NOT RESULT IN ANY PAYMENTS TO REDWOOD
PHARMA
Source text for Eikon: ID:nWkrbNSY10
Further company coverage: REDWPH.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached